TY  - GEN
AU  - Phillips,G L
AU  - Meisenberg,B
AU  - Reece,D E
AU  - Adams,V R
AU  - Badros,A
AU  - Brunner,J
AU  - Fenton,R
AU  - Filicko,J
AU  - Grosso,D
AU  - Hale,G A
AU  - Howard,D S
AU  - Johnson,V P
AU  - Kniska,A
AU  - Marshall,K W
AU  - Nath,R
AU  - Reed,E
AU  - Rapoport,A P
AU  - Takebe,N
AU  - Vesole,D H
AU  - Wagner,J L
AU  - Flomenberg,N
TI  - Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I study
SN  - 1083-8791
PY  - 2005///0429
KW  - Adult
KW  - Aged
KW  - Amifostine
KW  - administration & dosage
KW  - Cohort Studies
KW  - Disease-Free Survival
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - Female
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Melphalan
KW  - Middle Aged
KW  - Neoplasms
KW  - therapy
KW  - Transplantation, Autologous
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1016/j.bbmt.2004.03.001
ER  -